Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring
Boletín de Información Farmacoterapéutica de Navarra · 2025
DOI: 10.54095/bitn20253203en ↗Kurz gefasst
Fachartikel in der Zeitschrift Boletín de Información Farmacoterapéutica de Navarra, 2025. Verfasst von María Calvo Arbeloa.
Abstract (Originalsprache)
The main aim of clinical pharmacokinetics is to optimize pharmacotherapy. This requires an in-depth knowledge of the pharmacokinetic parameters and different population-based models. Its application requires a global vision that takes into account the state and clinical characteristics of the patient and the pharmacotherapeutic objectives. The most commonly monitored drugs are antimicrobial agents, digoxin, antiepileptics and immunosuppressants. Pharmacokinetic monitoring is particularly useful in specific populations or clinical situations, such as abnormal liver or kidney function, extreme ages or hypoalbuminaemia. Clinical pharmacokinetics units at hospitals are essential to ensure personalised medicine.
Zitieren
APA
Arbeloa, M. C. (2025). Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring. Boletín de Información Farmacoterapéutica de Navarra. https://doi.org/10.54095/bitn20253203en
Vancouver
Arbeloa MC. Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring. Boletín de Información Farmacoterapéutica de Navarra. 2025. doi:10.54095/bitn20253203en
BibTeX
@article{Arbeloa2025,
author = {Arbeloa, María Calvo},
title = {Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring},
journal = {Boletín de Información Farmacoterapéutica de Navarra},
year = {2025},
doi = {10.54095/bitn20253203en}
}
EUVIMED